The present study aimed, for the first time, to define the diagnostic accuracy of free circulating DNA in combination with mRNA expression levels of PPBP, haptoglobin and PADI4 in the peripheral blood of NSCLC patients. The gene discussed is PADI4; the disease is non-small cell lung carcinoma.